1. Submit the intake form
Share contact details, diagnosis information, exposure history, and the campaign you want reviewed.
Elmiron Lawsuit
Elmiron lawsuits are civil cases filed by people who took Elmiron and later suffered maculopathy or other major eyesight disorders. Janssen Pharmaceuticals allegedly knew about the potential of eye injury but failed to sufficiently notify the public, according to Elmiron lawsuits.
Elmiron Lawsuit Facts
Maculopathy, retinopathy and other vision problems
Janssen Pharmaceuticals, subsidiary of Johnson & Johnson
Beginning stages of litigation
Do I Qualify for an Elmiron Lawsuit?
Injuries in lawsuits include:
- Blurred vision
- Degenerative maculopathy
- Halo vision
- Macular retinopathy
- Macular/pattern dystrophy
- Maculopathy
- Metamorphopsia
- Pigmentary maculopathy
- Reduced night vision
- Retinal pigment epithelium atrophy
- Retinopathy
- Scotoma
- Unilateral or bilateral blindness
- Vision impairment
- Vision loss
Lawyers are considering lawsuits from persons who used Elmiron for at least two years and developed visual difficulties, particularly if they took it from 2018 to the present.
These vision impairments have to have started while you were using Elmiron or within a year of stopping it. If you stopped using Elmiron in 2010 and were diagnosed with an eye problem in 2011, you might be eligible.
Do you have eyesight difficulties after using Elmiron?
Free Case Review
When you contact a lawyer about a prospective Elmiron vision injury case, they may inquire about your personal experiences with the medicine. Make sure you include as much information as possible while answering questions.
Case Review Form
Evidence-informed Elmiron review
Elmiron lawsuit documentation and vision damage intake checklist
Elmiron reviews focus on prescription history, duration of use, and eye damage or vision loss diagnosis records that may be associated with long-term pentosan polysulfate use.
Evidence checklist
- Prescription records showing Elmiron (pentosan polysulfate sodium) use, dosage, and duration
- Eye exam records, retinal imaging, and ophthalmologist or retinal specialist diagnosis information
- Timeline of vision symptoms relative to Elmiron use start and stop dates
- Prior attorney or claim inquiry history
Sources used for intake education
These official references are provided for background education only. They do not replace medical or legal advice.
- FDA Elmiron label update — pigmentary maculopathy warningFDA drug-approval database entry for Elmiron including labeling history and safety updates.
2. Organize supporting details
Gather medical records, product history, proof of exposure, and timeline information that may help reviewers understand the claim.
3. Intake follow-up
AMMS or an intake partner may contact you for clarifying details before any potential legal review.
4. Legal review if appropriate
Qualified legal professionals decide whether a claim can move forward. AMMS does not provide legal advice or guarantee results.
Campaign-specific questions
What vision problems are associated with Elmiron?
Pigmentary maculopathy, a form of retinal damage, has been associated with long-term Elmiron use. Symptoms may include blurred vision, difficulty reading, and changes in central vision.
How long does someone typically need to have used Elmiron for a review to be relevant?
Intake reviewers typically look for multi-year use, as the research linking Elmiron to maculopathy generally involves longer-term exposure. Provide the full duration of use when submitting.
Related AMMS resources
AMMS Legal Intake Research TeamReviewed for intake accuracy by AMMS Compliance TeamLast reviewed: 2026-05-15
Important: AMMS provides intake and educational information. We are not providing medical or legal advice on this page, and submitting a form does not create an attorney-client relationship. Case value, eligibility, filing deadlines, and legal strategy must be reviewed by qualified professionals.